GMPs Guide COVID-19 Vaccine Manufacturing

October 16, 2020
Feliza Mirasol

Feliza Mirasol is science editor at BioPharm International.

BioPharm International, BioPharm International-10-15-2020, Volume 2020 eBook, Issue 3
Page Number: 9–10

Recent industry guidance aims to anchor rapid COVID-19 vaccine development in good manufacturing practice protocols.

Major bio/pharmaceutical companies and contract service providers leading the charge to bring COVID-19 vaccines to market are familiar with established good manufacturing practices (GMPs). To support manufacturers in the rush to develop a vaccine, FDA, in June 2020, released industry guidance highlighting the development and licensure of COVID-19 vaccines.

Read this article in BioPharm International’s Regulatory Sourcebook October 2020 eBook.

Article Details

BioPharm International
eBook: Regulatory Sourcebook, October 2020
October 2020
Pages: 9–10

Citation

When referring to this article, please cite it as F. Mirasol, “GMPs Guide COVID-19 Vaccine Manufacturing," BioPharm International Regulatory Sourcebook eBook (October 2020).